2,265 Shares in The Procter & Gamble Company (NYSE:PG) Purchased by Breed s Hill Capital LLC

Breed s Hill Capital LLC acquired a new position in shares of The Procter & Gamble Company (NYSE:PG) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 2,265 shares of the company’s stock, valued at approximately $332,000.

Several other hedge funds have also added to or reduced their stakes in the stock. Wellington Management Group LLP raised its stake in shares of Procter & Gamble by 9.4% during the 3rd quarter. Wellington Management Group LLP now owns 35,608,913 shares of the company’s stock valued at $5,193,916,000 after purchasing an additional 3,047,557 shares during the period. Northern Trust Corp grew its stake in Procter & Gamble by 2.3% during the third quarter. Northern Trust Corp now owns 29,313,150 shares of the company’s stock valued at $4,275,616,000 after acquiring an additional 670,862 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its stake in Procter & Gamble by 1.3% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 16,209,425 shares of the company’s stock worth $2,336,552,000 after purchasing an additional 206,165 shares in the last quarter. Royal Bank of Canada increased its holdings in shares of Procter & Gamble by 3.2% in the third quarter. Royal Bank of Canada now owns 11,170,305 shares of the company’s stock worth $1,629,299,000 after purchasing an additional 346,925 shares during the period. Finally, Fisher Asset Management LLC raised its position in shares of Procter & Gamble by 5.6% in the fourth quarter. Fisher Asset Management LLC now owns 10,556,988 shares of the company’s stock worth $1,547,021,000 after buying an additional 559,358 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Up 0.6 %

PG traded up $1.00 on Thursday, reaching $166.07. The company’s stock had a trading volume of 4,670,607 shares, compared to its average volume of 6,846,383. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.69 and a quick ratio of 0.48. The business’s 50 day moving average is $160.33 and its 200 day moving average is $154.57. The Procter & Gamble Company has a 1 year low of $141.45 and a 1 year high of $166.37. The stock has a market cap of $391.95 billion, a price-to-earnings ratio of 27.13, a price-to-earnings-growth ratio of 3.34 and a beta of 0.43.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.10. Procter & Gamble had a return on equity of 33.91% and a net margin of 18.00%. The firm had revenue of $20.20 billion for the quarter, compared to the consensus estimate of $20.43 billion. During the same quarter in the previous year, the company earned $1.37 EPS. The business’s revenue for the quarter was up .6% compared to the same quarter last year. As a group, research analysts forecast that The Procter & Gamble Company will post 6.55 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Friday, April 19th will be paid a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a yield of 2.42%. The ex-dividend date is Thursday, April 18th. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.69%.

Insider Activity at Procter & Gamble

In other news, COO Shailesh Jejurikar sold 31,859 shares of the stock in a transaction dated Monday, May 6th. The shares were sold at an average price of $164.90, for a total value of $5,253,549.10. Following the transaction, the chief operating officer now directly owns 9,739 shares of the company’s stock, valued at $1,605,961.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Procter & Gamble news, COO Shailesh Jejurikar sold 31,859 shares of Procter & Gamble stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $164.90, for a total transaction of $5,253,549.10. Following the transaction, the chief operating officer now directly owns 9,739 shares of the company’s stock, valued at approximately $1,605,961.10. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO R. Alexandra Keith sold 776 shares of the stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $158.11, for a total transaction of $122,693.36. Following the transaction, the chief executive officer now directly owns 4,859 shares in the company, valued at approximately $768,256.49. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 140,112 shares of company stock valued at $22,841,321. 0.17% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. UBS Group upped their target price on shares of Procter & Gamble from $172.00 to $178.00 and gave the stock a “buy” rating in a research report on Wednesday, January 24th. Argus lifted their price target on shares of Procter & Gamble from $180.00 to $185.00 and gave the stock a “buy” rating in a research note on Thursday, April 25th. Stifel Nicolaus increased their target price on shares of Procter & Gamble from $155.00 to $157.00 and gave the company a “hold” rating in a report on Wednesday, January 24th. JPMorgan Chase & Co. decreased their price objective on Procter & Gamble from $169.00 to $162.00 and set an “overweight” rating on the stock in a report on Thursday, January 18th. Finally, Royal Bank of Canada increased their target price on Procter & Gamble from $156.00 to $157.00 and gave the company a “sector perform” rating in a report on Wednesday, January 24th. Seven equities research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to data from MarketBeat, Procter & Gamble currently has a consensus rating of “Moderate Buy” and an average price target of $169.76.

Procter & Gamble Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.